RE: Interview20 Dec 2022 09:07
Could be a tie in with Astrazeneca ?
Lynparza® is approved for treatment of an increasing number of cancers, achieving sales of US$2.7bn in 2021 with industry analysts forecasting annual sales of US$9.7bn by 2028
Huge news here !!!